The Crisis Nobody in Finance Wants to Talk About

ESG investing — environmental, social, and governance — is a multi-trillion-dollar global industry. Pension funds, university endowments, and asset managers have poured enormous sums into it. It influences corporate boards, executive pay, and what companies get capital.

There's just one problem. A substantial portion of the academic research that gave ESG its credibility may be fraudulent, fabricated, or simply unrepeatable.

What the Replication Crisis Actually Means

The "replication crisis" refers to a documented, years-long failure in academic research: studies that get published, get cited, and shape policy — but when other researchers try to reproduce the results, they can't.

John Ioannidis, a professor of medicine at Stanford University, has been the leading voice on this for over two decades. His work revealed that a shocking percentage of published scientific findings simply don't hold up under scrutiny.

In 2023, German neuropsychologist Bernhard Sabel led a team that screened roughly 5,000 papers. According to reporting by Jeffrey Brainard at Science magazine, Sabel estimated up to 34% of neuroscience papers published in 2020 were likely made up or plagiarized. In medicine, the figure was 24%.

Nearly one in four medical studies — the kind that influence treatments and drug approvals — may be garbage.

Social Science Is Even Worse

Hard science gets the headlines when fraud surfaces. Social science barely gets a shrug.

But according to Stephen Soukup writing in The Daily Signal, the replication crisis in social sciences is likely even more widespread than in medicine or neuroscience. The difference is that most people assume social science research doesn't matter as much, so the corruption gets a pass.

That assumption crumbles when it comes to ESG.

ESG as an investment framework didn't come from thin air. It was built on an academic literature claiming that companies scoring high on environmental, social, and governance metrics outperform financially — and that ignoring these factors creates hidden risk. Institutional investors used that research to justify reshaping how capital gets allocated across entire economies.

If the underlying research is irreproducible — and a growing body of evidence suggests much of it is — then the investment case for ESG collapses.

The Finance World Is Starting to Notice

In January 2025, Man Group — one of the world's largest publicly traded hedge funds — published a podcast featuring Professor Andrew King of Boston University discussing exactly this problem. King addressed whether sustainable investing is facing its own replication crisis. The answer, based on his academic work, is yes.

Man Group manages tens of billions in assets. When they put a researcher on the record questioning the statistical foundations of sustainable finance, it signals where institutional capital is turning.

The issue is broader than ESG specifically. A LinkedIn post by finance academic Searat Ali highlighted peer-reviewed research asking directly: "Is there a replication crisis in finance?" The answer from that literature is uncomfortable — yes, finance research has the same methodological problems as other social sciences, including selective reporting, p-hacking (manipulating statistical thresholds to get publishable results), and data mining.

What BlackRock Quietly Admitted

The cracks were showing even before the research debate heated up.

According to a Thomson Reuters special report, the world's largest asset manager, BlackRock, slashed its support for U.S. shareholder ESG proposals by nearly half in 2022 — voting for just 24% of them, down sharply from prior years. BlackRock itself warned that ESG proposals were becoming "too prescriptive."

The Thomson Reuters report also noted that Russia's invasion of Ukraine in 2022 forced a brutal reality check: decades of ESG-driven fossil fuel divestment had left Europe dangerously dependent on Russian energy. Germany had to scramble. The green transition looked a lot less elegant when the lights might go out.

These moves illustrate how ESG was always operating more on ideology and optimistic modeling than on rigorous, verified science.

What Mainstream Coverage Gets Wrong

Most financial media treats ESG skepticism as a political story — red states versus blue states, Republicans versus BlackRock. That framing lets the industry off the hook.

The replication crisis isn't partisan. It's a scientific integrity problem. The question of whether ESG-linked studies can be independently verified has nothing to do with which party controls Congress. It's a question for statisticians and peer reviewers.

When outlets frame this as a culture war story, they avoid the harder, more important question: Was the academic foundation of a multi-trillion-dollar industry ever solid to begin with?

Evidence suggests not.

What This Means for Regular People

Your pension fund may have underperformed because managers chased ESG scores instead of returns — based on research that didn't replicate.

Public companies spent billions on ESG compliance, DEI bureaucracies, and sustainability reporting — costs passed to consumers and shareholders — justified by studies that may have been fabricated or statistically manipulated.

Governments wrote regulations around this research. Trillions in capital were redirected.

If the foundation is rotten, the building needs to come down. The financial industry owes investors a real answer — not PR, not politics. Just the data. Verified, replicated, honest data.

So far, they haven't delivered it.